Research published in the Neurology journal claims a significant breakthrough in the development of a blood test (for plasma Aβ42/Aβ40) which may be able to predict Alzheimer’s Disease onset with 94% accuracy.
“But it’s important to note this isn’t a blood test for dementia – it tells us that amyloid deposits are in the brain, which are a hallmark of Alzheimer’s Disease but are also found in healthy older people too.”
Alzheimer’s blood test ‘one step closer’. London: BBC Health News, August 2nd 2019.
This relates to:
Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).
Schindler, SE. Bollinger, JG. [and] Ovod, V. [et al] (2019). High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis. Neurology. August 1st 2019.
“Plasma Aβ42/Aβ40 could be used in prevention trials to screen for individuals likely to be amyloid PET-positive and at risk for Alzheimer disease dementia”.